Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest update is out from Everest Medicines Ltd. ( (HK:1952) ).
Everest Medicines Limited, listed on the Hong Kong Stock Exchange, experienced unusual market price and trading volume movements. The company attributes this to CBC Group, the controlling shareholder, selling 17.1 million shares to international investment institutions in a block trade. Despite this transaction, CBC Group maintains more than a 34% stake, indicating its ongoing commitment. The company’s board assured stakeholders of no material change in its operations or financial standing.
More about Everest Medicines Ltd.
YTD Price Performance: 3.82%
Average Trading Volume: 5,534,870
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$17.2B
For an in-depth examination of 1952 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue